25th Feb 2011 15:57
SCHEDULE 11
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.
(1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.
(2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.
(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
All relevant boxes should be completed in block capital letters
1 | Name of the Issuer UNITED DRUG PLC
| 2 | State whether the notification relates to: (i) a transaction notified in accordance with Market Abuse Rules;
(ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii)
|
3 | Name of DIRECTOR MR. LIAM FITZGERALD | 4 | State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person N/A |
5 | Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest AS PER 3 ABOVE | 6 | Description of shares (including class) debentures or derivatives or financial instruments relating to shares ORDINARY SHARES OF €0.05 EACH |
7 | Name of registered shareholder(s) and, if more than one, number of shares held by each of them MR. LIAM FITZGERALD | 8 | State the nature of the transaction ELECTION OF SCRIP DIVIDEND ALTERNATIVE OFFER RELATING TO FINAL DIVIDEND FOR YEAR ENDING 30 SEPTEMBER 2010 |
9 | Number of shares, debentures or financial instruments relating to shares acquired 6,860 ORDINARY SHARES OF €0.05 EACH | 10 | Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) 0.002% |
11 | Number of shares, debentures or financial instruments relating to shares disposed N/A
| 12 | Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) N/A |
13 | Price per share or value of transaction
6,860 @ €2.12
| 14 | Date and place of transaction 25 FEBRUARY 2011 |
15 | Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) 762,017 ORDINARY SHARES OF €0.05 EACH (0.3%)
| 16 | Date issuer informed of transaction 25 FEBRUARY 2011 |
If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:
17 | Date of grant | 18 | Period during which or date on which it can be exercised
|
19 | Total amount paid (if any) for grant of the option
| 20 | Description of shares or debentures involved (class and number)
|
21 | Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise | 22 | Total number of shares or debentures over which options are held following notification
|
23 | Any additional information N/A | 24 | Name of contact and telephone number for queries KAREN GEOGHEGAN (01-4637720) |
Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 25/02/2011 |
SCHEDULE 11
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.
(5) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.
(6) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.
(7) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.
(8) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
All relevant boxes should be completed in block capital letters
1 | Name of the Issuer UNITED DRUG PLC
| 2 | State whether the notification relates to: (i) a transaction notified in accordance with Market Abuse Rules;
(ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii)
|
3 | Name of DIRECTOR MR. HUGH FRIEL | 4 | State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person N/A |
5 | Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest AS PER 3 ABOVE | 6 | Description of shares (including class) debentures or derivatives or financial instruments relating to shares ORDINARY SHARES OF €0.05 EACH |
7 | Name of registered shareholder(s) and, if more than one, number of shares held by each of them MR. HUGH FRIEL | 8 | State the nature of the transaction ELECTION OF SCRIP DIVIDEND ALTERNATIVE OFFER RELATING TO FINAL DIVIDEND FOR YEAR ENDING 30 SEPTEMBER 2010 |
9 | Number of shares, debentures or financial instruments relating to shares acquired 461 ORDINARY SHARES OF €0.05 EACH | 10 | Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) 0.0001% |
11 | Number of shares, debentures or financial instruments relating to shares disposed N/A
| 12 | Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) N/A |
13 | Price per share or value of transaction
461 @ €2.12
| 14 | Date and place of transaction 25 FEBRUARY 2011 |
15 | Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) 20,611 ORDINARY SHARES OF €0.05 EACH (0.008%)
| 16 | Date issuer informed of transaction 25 FEBRUARY 2011 |
If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:
17 | Date of grant | 18 | Period during which or date on which it can be exercised
|
19 | Total amount paid (if any) for grant of the option
| 20 | Description of shares or debentures involved (class and number)
|
21 | Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise | 22 | Total number of shares or debentures over which options are held following notification
|
23 | Any additional information N/A | 24 | Name of contact and telephone number for queries KAREN GEOGHEGAN (01-4637720) |
Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 25/02/2011 |
SCHEDULE 11
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.
(9) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.
(10) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.
(11) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.
(12) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
All relevant boxes should be completed in block capital letters
1 | Name of the Issuer UNITED DRUG PLC
| 2 | State whether the notification relates to: (i) a transaction notified in accordance with Market Abuse Rules;
(ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii)
|
3 | Name of PERSON DISCHARGING MANAGERIAL RESPONSIBIILITY MR. MIKE GANNON | 4 | State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person N/A |
5 | Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest AS PER 3 ABOVE | 6 | Description of shares (including class) debentures or derivatives or financial instruments relating to shares ORDINARY SHARES OF €0.05 EACH |
7 | Name of registered shareholder(s) and, if more than one, number of shares held by each of them MR. MIKE GANNON | 8 | State the nature of the transaction ELECTION OF SCRIP DIVIDEND ALTERNATIVE OFFER RELATING TO FINAL DIVIDEND FOR YEAR ENDING 30 SEPTEMBER 2010 |
9 | Number of shares, debentures or financial instruments relating to shares acquired 177 ORDINARY SHARES OF €0.05 EACH | 10 | Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) 0.00007% |
11 | Number of shares, debentures or financial instruments relating to shares disposed N/A
| 12 | Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) N/A |
13 | Price per share or value of transaction
177 @ €2.12
| 14 | Date and place of transaction 25 FEBRUARY 2011 |
15 | Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) 7,903 ORDINARY SHARES OF €0.05 EACH (0.003%)
| 16 | Date issuer informed of transaction
25 FEBRUARY 2011 |
If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:
17 | Date of grant
| 18 | Period during which or date on which it can be exercised
|
19 | Total amount paid (if any) for grant of the option
| 20 | Description of shares or debentures involved (class and number)
|
21 | Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise
| 22 | Total number of shares or debentures over which options are held following notification
|
23 | Any additional information N/A | 24 | Name of contact and telephone number for queries KAREN GEOGHEGAN (01-4637720) |
Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 25/02/2011 |
SCHEDULE 11
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.
(13) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.
(14) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.
(15) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.
(16) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
All relevant boxes should be completed in block capital letters
1 | Name of the Issuer UNITED DRUG PLC
| 2 | State whether the notification relates to: (i) a transaction notified in accordance with Market Abuse Rules;
(ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii)
|
3 | Name of PERSON DISCHARGING MANAGERIAL RESPONSIBILITY MS. KAREN GEOGHEGAN | 4 | State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person N/A |
5 | Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest AS PER 3 ABOVE | 6 | Description of shares (including class) debentures or derivatives or financial instruments relating to shares ORDINARY SHARES OF €0.05 EACH |
7 | Name of registered shareholder(s) and, if more than one, number of shares held by each of them MS. KAREN GEOGHEGAN | 8 | State the nature of the transaction ELECTION OF SCRIP DIVIDEND ALTERNATIVE OFFER RELATING TO FINAL DIVIDEND FOR YEAR ENDING 30 SEPTEMBER 2010 |
9 | Number of shares, debentures or financial instruments relating to shares acquired 335 ORDINARY SHARES OF €0.05 EACH | 10 | Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) 0.0001% |
11 | Number of shares, debentures or financial instruments relating to shares disposed N/A
| 12 | Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) N/A |
13 | Price per share or value of transaction
335 @ €2.12
| 14 | Date and place of transaction 25 FEBRUARY 2011 |
15 | Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) 14,990 ORDINARY SHARES OF €0.05 EACH (0.006%)
| 16 | Date issuer informed of transaction 25 FEBRUARY 2011 |
If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:
17 | Date of grant
| 18 | Period during which or date on which it can be exercised
|
19 | Total amount paid (if any) for grant of the option
| 20 | Description of shares or debentures involved (class and number)
|
21 | Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise
| 22 | Total number of shares or debentures over which options are held following notification
|
23 | Any additional information N/A | 24 | Name of contact and telephone number for queries KAREN GEOGHEGAN (01-4637720) |
Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 25/02/2011 |
SCHEDULE 11
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.
(17) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.
(18) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.
(19) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.
(20) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
All relevant boxes should be completed in block capital letters
1 | Name of the Issuer UNITED DRUG PLC
| 2 | State whether the notification relates to: (i) a transaction notified in accordance with Market Abuse Rules;
(ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii)
|
3 | Name of DIRECTOR MR. BARRY MCGRANE | 4 | State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person N/A |
5 | Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest AS PER 3 ABOVE | 6 | Description of shares (including class) debentures or derivatives or financial instruments relating to shares ORDINARY SHARES OF €0.05 EACH |
7 | Name of registered shareholder(s) and, if more than one, number of shares held by each of them MR. BARRY MCGRANE | 8 | State the nature of the transaction ELECTION OF SCRIP DIVIDEND ALTERNATIVE OFFER RELATING TO FINAL DIVIDEND FOR YEAR ENDING 30 SEPTEMBER 2010 |
9 | Number of shares, debentures or financial instruments relating to shares acquired 15,475 ORDINARY SHARES OF €0.05 EACH | 10 | Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) 0.006% |
11 | Number of shares, debentures or financial instruments relating to shares disposed N/A
| 12 | Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) N/A |
13 | Price per share or value of transaction
15,475 @ €2.12
| 14 | Date and place of transaction 25 FEBRUARY 2011 |
15 | Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) 692,184 ORDINARY SHARES OF €0.05 EACH (0.2%)
| 16 | Date issuer informed of transaction 25 FEBRUARY 2011 |
If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:
17 | Date of grant
| 18 | Period during which or date on which it can be exercised
|
19 | Total amount paid (if any) for grant of the option
| 20 | Description of shares or debentures involved (class and number)
|
21 | Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise
| 22 | Total number of shares or debentures over which options are held following notification
|
23 | Any additional information N/A | 24 | Name of contact and telephone number for queries KAREN GEOGHEGAN (01-4637720) |
Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 25/02/2011 |
SCHEDULE 11
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.
(21) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.
(22) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.
(23) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.
(24) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
All relevant boxes should be completed in block capital letters
1 | Name of the Issuer UNITED DRUG PLC
| 2 | State whether the notification relates to: (i) a transaction notified in accordance with Market Abuse Rules;
(ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii)
|
3 | Name of DIRECTOR MR. ALAN RALPH | 4 | State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person N/A |
5 | Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest AS PER 3 ABOVE | 6 | Description of shares (including class) debentures or derivatives or financial instruments relating to shares ORDINARY SHARES OF €0.05 EACH |
7 | Name of registered shareholder(s) and, if more than one, number of shares held by each of them MR. ALAN RALPH (27,655) GOODBODY STOCKBROKERS NOMINEES LIMITED (69,933)
| 8 | State the nature of the transaction ELECTION OF SCRIP DIVIDEND ALTERNATIVE OFFER RELATING TO FINAL DIVIDEND FOR YEAR ENDING 30 SEPTEMBER 2010 |
9 | Number of shares, debentures or financial instruments relating to shares acquired 2,180 ORDINARY SHARES OF €0.05 EACH | 10 | Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) 0.0008% |
11 | Number of shares, debentures or financial instruments relating to shares disposed N/A
| 12 | Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) N/A |
13 | Price per share or value of transaction
2,180 @ €2.12
| 14 | Date and place of transaction 25 FEBRUARY 2011 |
15 | Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) 97,588 ORDINARY SHARES OF €0.05 EACH (0.04%)
| 16 | Date issuer informed of transaction 25 FEBRUARY 2011 |
If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:
17 | Date of grant | 18 | Period during which or date on which it can be exercised
|
19 | Total amount paid (if any) for grant of the option
| 20 | Description of shares or debentures involved (class and number)
|
21 | Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise
| 22 | Total number of shares or debentures over which options are held following notification
|
23 | Any additional information N/A | 24 | Name of contact and telephone number for queries KAREN GEOGHEGAN (01-4637720) |
Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 25/02/2011 |
SCHEDULE 11
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.
(25) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.
(26) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.
(27) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.
(28) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
All relevant boxes should be completed in block capital letters
1 | Name of the Issuer UNITED DRUG PLC
| 2 | State whether the notification relates to: (i) a transaction notified in accordance with Market Abuse Rules;
(ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii)
|
3 | Name of DIRECTOR MR. PHILIP TOOMEY | 4 | State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person N/A |
5 | Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest AS PER 3 ABOVE | 6 | Description of shares (including class) debentures or derivatives or financial instruments relating to shares ORDINARY SHARES OF €0.05 EACH |
7 | Name of registered shareholder(s) and, if more than one, number of shares held by each of them MR. PHILIP TOOMEY & MRS. CATHERINE TOOMEY | 8 | State the nature of the transaction ELECTION OF SCRIP DIVIDEND ALTERNATIVE OFFER RELATING TO FINAL DIVIDEND FOR YEAR ENDING 30 SEPTEMBER 2010 |
9 | Number of shares, debentures or financial instruments relating to shares acquired 1,886 ORDINARY SHARES OF €0.05 EACH | 10 | Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) 0.0007% |
11 | Number of shares, debentures or financial instruments relating to shares disposed N/A
| 12 | Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) N/A |
13 | Price per share or value of transaction
1,886 @ €2.12
| 14 | Date and place of transaction 25 FEBRUARY 2011 |
15 | Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) 84,334 ORDINARY SHARES OF €0.05 EACH (0.03%)
| 16 | Date issuer informed of transaction 25 FEBRUARY 2011 |
If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:
17 | Date of grant | 18 | Period during which or date on which it can be exercised
|
19 | Total amount paid (if any) for grant of the option
| 20 | Description of shares or debentures involved (class and number)
|
21 | Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise
| 22 | Total number of shares or debentures over which options are held following notification
|
23 | Any additional information N/A | 24 | Name of contact and telephone number for queries KAREN GEOGHEGAN (01-4637720) |
Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 25/02/2011 |
Related Shares:
UDG.L